These data support a role for VDR-dependent, 1,25(OH)2D3-mediated increase of TCF-4 in mouse mammary and human colorectal tumor cells, the effects of which may differentially regulate β-catenin activity in vivo. Here, TCF4 is linked to colorectal neoplasm.